Compare PVLA & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PVLA | HLF |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | N/A | 2004 |
| Metric | PVLA | HLF |
|---|---|---|
| Price | $144.13 | $13.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $171.87 | $18.00 |
| AVG Volume (30 Days) | 290.1K | ★ 1.6M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $5,037,500,000.00 |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | $104,350.18 | $3.80 |
| P/E Ratio | ★ N/A | $22.63 |
| Revenue Growth | N/A | ★ 0.89 |
| 52 Week Low | $26.19 | $7.56 |
| 52 Week High | $161.38 | $20.40 |
| Indicator | PVLA | HLF |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 56.32 |
| Support Level | $106.07 | $12.55 |
| Resistance Level | $156.28 | $17.51 |
| Average True Range (ATR) | 10.13 | 0.55 |
| MACD | 1.21 | 0.13 |
| Stochastic Oscillator | 65.47 | 80.44 |
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.